Goals of the Discover Platform include generating novel vaccine candidates. Participating organisations specialise in inducing potent neutralising antibodies and non-neutralising antibodies and T-cell responses. [as research progresses a pipeline diagram can be added]
Publication list
For participants registered at the IAS meeting, EHVA is organising a satellite symposium to provide an overview of the latest developments in HIV prevention broadly, and prophylactic and therapeutic HIV vaccines in particular, as well as introduce key areas of work for EHVA.
 |
This project has received funding from the European Union's Horizon 2020 research |